Catheter Precision (VTAK) announced that the United States Patent and Trademark Office, USPTO, has issued a Notice of Allowance for key claims covering its proprietary surgical vessel closing pressure device, marking a significant milestone in the Company’s intellectual property strategy. Following an examination process, the USPTO confirmed the novelty and patentability of VTAK’s technology over existing prior art. The allowed claims provide protection across both the core device architecture and its method of use, creating a comprehensive and defensible intellectual property position around a foundational component of the Company’s platform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision agreement to acquire Fly Flyte obtains shareholder approval
- Catheter Precision Shareholders Approve Reverse Split, Capital Changes
- Catheter Precision engages advisor to sell cardiac electrophysiology business
- Catheter Precision announces launch of Flyte Hops Florida
- Catheter Precision secures up to $88M in institutional financing commitments